Current Developments in the Synthesis and Biological Activity of HIV-1 Double-Drug Inhibitors

E-ISSN： 1875-533x|14|11|1207-1220

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.14, Iss.11, 2007-05, pp. : 1207-1220

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Computer-Aided Design, Synthesis, and Biological Activity Evaluation of Potent Fusion Inhibitors Targeting HIV-1 gp41

Medicinal Chemistry, Vol. 7, Iss. 4, 2011-07 ,pp. : 309-316

Bentham Science Publishers

Access to resources Recommend Favorite

Design, Synthesis and Biological Activity of Aromatic Diketone Derivatives as HIV-1 Integrase Inhibitors

Medicinal Chemistry, Vol. 11, Iss. 2, 2015-03 ,pp. : 180-187

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and Biological Evaluation of Benzophenone Derivatives as Potential HIV-1 Inhibitors

Medicinal Chemistry, Vol. 13, Iss. 4, 2017-05 ,pp. : 398-405

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and activity of HIV protease inhibitors

By Garrouste P. Pawlowski M. Tonnaire T. Sicsic S. Dumy P. de Rosny E. Reboud-Ravaux M. Fulcrand P. Martinez J.

European Journal of Medicinal Chemistry, Vol. 33, Iss. 6, 1998-06 ,pp. : 423-436

Elsevier

Access to resources Recommend Favorite

Recent Developments of Peptidomimetic HIV-1 Protease Inhibitors

Current Medicinal Chemistry, Vol. 18, Iss. 29, 2011-10 ,pp. : 4513-4537

Bentham Science Publishers

Access to resources Recommend Favorite